Table 2.

Multinomial and logistic regression odds of poor ambulatory function of cancer survivors compared with cancer-free controls.

CasesWalkORCasesMobility disability
CancerNo.pace(95% CI)No.OR (95% CI)
All cancersa29,468Slow1.42d (1.30–1.54)30,4031.24c (1.17–1.31)
Normal1.20d (1.11–1.29)
Brisk (ref)1.00
Respiratoryb1,257Slow2.62d (2.24–3.05)1,3171.95d (1.77–2.14)
Normal1.49d (1.29–1.73)
Brisk (ref)1.00
Oral451Slow1.97d (1.56–2.48)4691.60d (1.37–1.88)
Normal1.33c (1.08–1.64)
Brisk (ref)1.00
Soft tissue107Slow1.92c (1.13–3.24)1161.46c (1.04–2.05)
Normal1.68c (1.05–2.67)
Brisk (ref)1.00
Stomach124Slow1.72c (1.06–2.78)1281.18 (0.87–1.60)
Normal1.49 (0.95–2.33)
Brisk (ref)1.00
Ovarian127Slow1.44 (0.90–2.31)1351.23 (0.91–1.66)
Normal1.37 (0.88–2.12)
Brisk (ref)1.00
Urinary2,483Slow1.42d (1.28–1.57)2,5741.27d (1.18–1.36)
Normal1.18c (1.08–1.29)
Brisk (ref)1.00
Colon2,026Slow1.37d (1.22–1.53)2,0981.21d (1.12–1.30)
Normal1.17c (1.05–1.30)
Brisk (ref)1.00
Rectum795Slow1.32c (1.11–1.57)8271.15c (1.02–1.30)
Normal1.22c (1.04–1.42)
Brisk (ref)1.00
Endocrine275Slow1.24 (0.92–1.66)2841.20 (0.97–1.48)
Normal1.05 (0.81–1.38)
Brisk (ref)1.00
Endometrial784Slow1.18 (0.96–1.43)8441.15c (1.02–1.31)
Normal1.04 (0.86–1.25)
Brisk (ref)1.00
Non-Hodgkin lymphoma635Slow1.12 (0.92–1.37)6591.11 (0.96–1.28)
Normal1.04 (0.87–1.24)
Brisk (ref)1.00
Breast5,045Slow1.11c (1.03–1.20)5,2981.07c (1.02–1.12)
Normal1.06 (0.99–1.14)
Brisk (ref)1.00
Prostate11,801Slow1.05c (1.01–1.10)11,9971.05c (1.01–1.08)
Normal1.00 (0.97–1.04)
Brisk (ref)1.00
Vulva109Slow0.95 (0.59–1.53)1160.91 (0.67–1.25)
Normal1.06 (0.68–1.63)
Brisk (ref)1.00
Melanoma2,428Slow0.86c (0.77–0.95)2,4740.88c (0.81–0.95)
Normal0.95 (0.88–1.04)
Brisk (ref)1.00
  • Note: Covariates: age, sex, race, highest level of education, years of follow-up, BMI, self-reported health status, and frailty index. Sorted by walking pace strength of association.

  • Abbreviations: BMI, body mass index; M, mean; SD, standard deviation.

  • aAlso adjusted for cancer type.

  • bRespiratory system includes cancers of the nose, nasal cavity, middle ear, larynx, lung and bronchus, pleura, trachea, mediastinum, and other respiratory.

  • cP = 0.05.

  • dP < 0.001.